Why does a SVP of a $380M Bio-Tech (trading as high $20) move to a $7.5M Bio-Tech? InMed Appoints Paul Brennan as President & Chief Executive Officer: from NASDAQ:ABUS to OTCQB:IMLFF Sym:IMLFF hmmmm...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.